Results from short-, medium- and long-term follow-up

Follow-Up and PatientsOutcome with O2-O3Outcome with Steroid
ExcellentGoodPoorExcellentGoodPoor
Short term
    With disk disease (n = 166)73 (84.8%)8 (9.3%)5 (5.9%)64 (80%)10 (12.5%)8 (10%)
    Without disk disease (n = 160)56 (80%)11 (15.7%)3 (4.3%)55 (78.5%)9 (12.8%)5 (7.2%)
Medium term
    With disk disease (n = 166)67 (77.9%)9 (10.5%)10 (11.6%)54 (67.5%)14 (17.5%)12 (15%)
    Without disk disease (n = 160)55 (78.5%)9 (12.9%)6 (8.6%)49 (70%)10 (14.2%)11 (15.8%)
Long term
    With disk disease (n = 166)64 (74.4%)9 (10.5%)13 (15.1%)46 (57.5%)16 (20%)18 (22.5%)
    Without disk disease (n = 160)53 (75.8%)11 (15.7%)6 (8.6%)44 (62.8%)11 (15.8%)15 (21.4%)
  • Note.—Data in parentheses are percentages. Short term = 1 week, medium term = 3 months, and long term = 6 months.